6 citations Evaluation of arsenic trioxide by the pediatric preclinical testing program with a focus on Ewing sarcoma.

Smith, M. A.,Kang, M. H.,Reynolds, C. P.,Kurmasheva, R. T.,Alexander, D.,Billups, C. A.,Toretsky, J. A.,Houghton, P. J.; Pediatr Blood Cancer. 2012 Feb 09.

17 citations Initial testing of the investigational NEDD8-activating enzyme inhibitor MLN4924 by the pediatric preclinical testing program.

Smith, M. A.,Maris, J. M.,Gorlick, R.,Kolb, E. A.,Lock, R.,Carol, H.,Keir, S. T.,Reynolds, C. P.,Kang, M. H.,Morton, C. L.,Wu, J.,Smith, P. G.,Yu, J.,Houghton, P. J.; Pediatr Blood Cancer. 2011 Oct 21.

7 citations Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing program.

Smith, M. A.,Maris, J. M.,Lock, R.,Kolb, E. A.,Gorlick, R.,Keir, S. T.,Carol, H.,Morton, C. L.,Reynolds, C. P.,Kang, M. H.,Houghton, P. J.; Pediatr Blood Cancer. 2011 Mar 02.